Eicosapentaenoic acid-rich essential fatty acid supplementation in chronic fatigue syndrome associated with symptom remission and structural brain changes

International Journal of Clinical Practice

Volumn 58, Issue 3, 2004, Pages 297-299

  Puri, B K ^a   Holmes, J ^a   Hamilton, G ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; EYE Q; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID;

ADULT; ARTICLE; BRAIN SIZE; BRAIN VENTRICLE DILATATION; CASE REPORT; CHRONIC FATIGUE SYNDROME; DIAGNOSTIC ACCURACY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; LATERAL BRAIN VENTRICLE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; SPECTROSCOPY; TREATMENT OUTCOME;

ADULT; BRAIN; DIETARY SUPPLEMENTS; EICOSAPENTAENOIC ACID; FATIGUE SYNDROME, CHRONIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 2342445103     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2004.00073.x     Document Type: Article

References (14)

1. Fukuda K, Strauss SE, Hickie I et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1995; 123: 74-6.
2. Lange G, Holodny AI, DeLuca J et al. Quantitative assessment of cerebral ventricular volumes in chronic fatigue syndrome. Appl Neuropsychol 2001; 8: 23-30.
3. Puri BK, Counsell SJ, Zaman et al. Relative increase in choline in the occipital cortex in chronic fatigue syndrome. Acta Psychiatr Scand 2002; 106: 224-6.
4. Chaudhuri A, Condon BR, Gow JW, Brennan D, Hadley DM. Proton magnetic resonance spectroscopy of basal ganglia in chronic fatigue syndrome. Neuroreport 2003; 14: 225-8.
5. Horrobin DF. Fatty acids, phospholipids and schizophrenia. In: Yehuda S, Mostofsky DI, eds. Handbook of EFA Biology: Biochemistry, Physiology and Behavioral Neurobiology. Totawa, NJ: Hummana Press 1997: 245-56.
6. Puri BK. Assessment of cerebral structure and function in neurodevelopmental disorders using structural magnetic resonance imaging, monomodal registration, and magnetic resonance spectroscopy. Prostaglandins Leukot Essent Fatty Acids (in press).
7. Bydder GM. Detection of small changes to the brain with serial magnetic resonance imaging. Br J Radiol 1995; 68: 1271-95.
8. Hajnal JV, Saeed N, Soar EJ, Oatridge A, Young IR, Bydder GM. A registration and interpolation procedure for subvoxel matching of serially acquired MR images. J Comput Assist Tomogr 1995; 19: 289-96.
9. Saeed N, Puri BK, Oatridge A, Hajnal JV, Young IR. Two methods for semi-automated quantification of changes in ventricular volume and their use in schizophrenia. Magn Reson Med 1998; 16: 1237-47.
10. Puri BK. Serial Neuroimaging in Schizophrenia Using Image Segmentation, Subvoxel Registration, and Quantitation. Ph D Thesis. London: University of London, 2001.
11. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-9.
12. Horrobin DF, Glen AIM, Vaddadi K. The membrane hypothesis of schizophrenia. Schizophr Res 1994; 13: 195-207.
13. Horrobin DF. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 1998; 30: 193-208.
14. Horrobin DF. Essential fatty acids and the post-viral fatigue syndrome. In: Jenkins R, Mowbray, eds. Post-Viral Fatigue Syndrome. Chichester: John Wiley, 1991: 393-404.